Recent trends in pediatric fluid therapy

K Miyasaka1, N Shimizu, J Kojima

  • 1Department of Anesthesia and ICU, National Center for Child Health and Development, Setagaya, Tokyo, Japan. miyasaka-k@ncchd.go.jp

Insights

Pediatric fluid therapy requires updates due to increased illness severity. This review examines modern challenges like SIADH and DKA, and evolving practices in pediatric fluid management.

Area of Science:

  • Pediatric Medicine
  • Intravenous Fluid Therapy
  • Nephrology

Background:

  • Current pediatric fluid therapy practices originated in the 1950s, assuming normal homeostasis.
  • Advances in pediatric medicine have led to more complex cases where normal physiology cannot be assumed.
  • Traditional fluid therapy is challenged by conditions like SIADH, CSWS, DKA, and hyponatremia.

Purpose of the Study:

  • To provide an overview of recent advancements and understanding in pediatric fluid therapy.
  • To discuss evolving practices in managing complex fluid and electrolyte imbalances in critically ill children.
  • To highlight emerging trends such as the use of acetate and non-albumin plasma expanders.

Main Methods:

  • Review of current literature and clinical understanding of pediatric fluid therapy.
  • Analysis of challenges posed by specific conditions affecting sodium and osmolarity balance.
  • Discussion of recent shifts in therapeutic approaches and agent selection.

Main Results:

  • Traditional fluid therapy approaches are insufficient for current pediatric patient populations.
  • Conditions such as SIADH, CSWS, DKA, and hyponatremia present significant challenges to fluid management.
  • The use of acetate as a bicarbonate precursor and non-albumin plasma expanders are becoming increasingly relevant.

Conclusions:

  • Pediatric fluid therapy requires significant updates to address the complexities of modern pediatric critical care.
  • Understanding and managing electrolyte and osmolarity dynamics is crucial for preventing CNS complications.
  • Future pediatric fluid management will likely incorporate acetate and novel plasma expanders.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...